ID   YES-3
AC   CVCL_E323
DR   Wikidata; Q54995402
RX   DOI=10.5833/jjgs.27.1885;
RX   PubMed=1770930;
RX   PubMed=8590302;
RX   PubMed=8974001;
RX   PubMed=18575732;
RX   PubMed=20515944;
CC   Population: Japanese.
CC   Doubling time: 61.0 hours (PubMed=1770930); 49.2 hours (DOI=10.5833/jjgs.27.1885).
CC   HLA typing: A*04,24; B*01,15; C*01 (PubMed=18575732).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
RX   DOI=10.5833/jjgs.27.1885;
RA   Kusanagi H.;
RT   "Effect of epidermal growth factor (EGF) on human esophageal cancer
RT   cell lines in a protein-free medium and the expression of EGF
RT   receptors on the cells.";
RL   Nihon Shokaki Geka Gakkai Zasshi 27:1885-1891(1994).
//
RX   PubMed=1770930;
RA   Murakami T., Nakamura M., Kusanagi H., Suzuki T.;
RT   "Establishment and characterization of human esophageal carcinoma cell
RT   lines -- especially the role of the serum-free culture.";
RL   Nihon Geka Gakkai Zasshi 92:1563-1570(1991).
//
RX   PubMed=8590302; DOI=10.1089/jir.1995.15.1005;
RA   Oka M., Hirose K., Iizuka N., Aoyagi K., Yamamoto K., Abe T.,
RA   Hazama S., Suzuki T.;
RT   "Cytokine mRNA expression patterns in human esophageal cancer cell
RT   lines.";
RL   J. Interferon Cytokine Res. 15:1005-1009(1995).
//
RX   PubMed=8974001; DOI=10.1089/jir.1996.16.1001;
RA   Oka M., Iizuka N., Yamamoto K., Gondo T., Abe T., Hazama S.,
RA   Akitomi Y., Koishihara Y., Ohsugi Y., Ooba Y., Ishihara T.,
RA   Suzuki T.;
RT   "The influence of interleukin-6 on the growth of human esophageal
RT   cancer cell lines.";
RL   J. Interferon Cytokine Res. 16:1001-1006(1996).
//
RX   PubMed=18575732; DOI=10.3892/or.20.1.155;
RA   Kawaoka T., Oka M., Takashima M., Ueno T., Yamamoto K., Yahara N.,
RA   Yoshino S., Hazama S.;
RT   "Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes
RT   stimulated by the MUC1-expressing human pancreatic cancer cell line
RT   YPK-1.";
RL   Oncol. Rep. 20:155-163(2008).
//
RX   PubMed=20515944; DOI=10.1158/1535-7163.MCT-09-0918; PMCID=PMC2884061;
RA   Seki N., Toh U., Sayers T.J., Fujii T., Miyagi M., Akagi Y.,
RA   Kusukawa J., Kage M., Shirouzu K., Yamana H.;
RT   "Bortezomib sensitizes human esophageal squamous cell carcinoma cells
RT   to TRAIL-mediated apoptosis via activation of both extrinsic and
RT   intrinsic apoptosis pathways.";
RL   Mol. Cancer Ther. 9:1842-1851(2010).
//